In 2021, the global ticagrelor market stood at USD 1,422 million. Recording a CAGR of 6.8% from 2022 to 2028, the worth is projected to reach ~USD 2,254 million by 2028, according to a new report by Gen Consulting Company.

This industry report offers market estimates of the global market, followed by a detailed analysis of the dosage, route of administration, application, end user, and region. The global market data on ticagrelor can be segmented by dosage: 90mg, 60mg. Ticagrelor market is further segmented by route of administration: nasogastric tube, oral. Based on application, the ticagrelor market is segmented into: acute coronary syndrome, cardiac surgery. On the basis of end user, the ticagrelor market also can be divided into: ambulatory surgery centers (ASCs), hospitals & clinics, others. Ticagrelor market by region is categorized into: North America, Asia Pacific, Europe, Rest of the World (ROW).

The competitive landscape of the market is highly consolidated and dominated by key players such as AstraZeneca plc.

The data-centric report focuses on market trends, status and outlook for segments. With comprehensive market assessment across the major geographies, the report is a valuable asset for the existing players, new entrants and the future investors.

Why buy this report?
– Get a detailed picture of the Global Ticagrelor Market
– Identify segments/areas to invest in over the forecast period in the Global Ticagrelor Market
– Understand the competitive environment, the market’s leading players
– The market estimate for ease of analysis across scenarios in Excel format.
– Strategy consulting and research support for three months.
– Print authentication provided for the single-user license.